mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.9 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |